Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive...
October 3, 2026
Share
Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.